2011, Number 95
Staphylococcus aureus: From genomics to clinical
Language: Spanish
References: 19
Page: 91-94
PDF size: 144.25 Kb.
Text Extraction
No abstractREFERENCES
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):18-55.
Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin- Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications. Clin Microbiol Rev. 2010;1(23):99-139.
Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, Gagnon F, Truchon K, Bastien M, Picard FJ, van Belkum A, Ouellette M, Roy PH, Bergeron MG. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol. 2004;42(5):1875-84.